Pharma Foods International Co., Ltd. provided consolidated earnings guidance for the year ending July 31, 2024. For the year, the company expects net sales of ¥72,047 million, operating profit of ¥3,300million, profit attributable to owners of the parent of ¥2,784 million, and earnings per share of ¥96.55.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
879 JPY | +1.27% | +2.57% | -12.48% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-12.48% | 157M | |
+22.56% | 46.71B | |
-1.51% | 41.52B | |
+48.83% | 41.8B | |
-3.42% | 29.55B | |
+10.13% | 25.78B | |
-20.44% | 19.26B | |
+26.45% | 11.98B | |
-0.14% | 12.14B | |
-0.47% | 12.08B |
- Stock Market
- Equities
- 2929 Stock
- News Pharma Foods International Co., Ltd.
- Pharma Foods International Co., Ltd. Provides Consolidated Earnings Guidance for the Year Ending July 31, 2024